ACCURAY INCORPORATED

NASDAQ: ARAY (Accuray Incorporated)

最近更新时间: 25分钟之前

2.80

-0.28 (-9.09%)

前收盘价格 3.08
成交量 140,573
价格/销量 (P/S) 0.020
股市价格/股市净资产 (P/B) 0.170
52周波幅
2.75 (-1%) — 45.20 (1514%)
营业毛利率 0.14%
营业利益率 (TTM) 3.73%
季度收入增长率 (YOY) 16.80%
总债务/股东权益 (D/E MRQ) 289.67%
流动比率 (MRQ) 1.64
营业现金流 (OCF TTM) 22.45 M
杠杆自由现金流 (LFCF TTM) 23.73 M
资产报酬率 (ROA TTM) 1.72%
股东权益报酬率 (ROE TTM) 1.48%

AIStockmoo 评分

-2.0
价值 38% -1.3
AI Insight 参考 NA
相对估值 参考 NA
财务健康 参考 -1.3
时机 38% -2.5
AI Technical 参考 NA
技术振荡指标 参考 -2.5
技术平均移动指标 参考 -2.5
市场情绪 25% 0.1
分析师共识 参考 0.0
新闻情绪 参考 0.4
聪明钱 NA
内部交易活动 参考 NA
机构资金流 参考 NA
空头持仓 参考 NA
市场环境 ×1.16
宏观环境 参考 -3.3
行业对比大市 (6个月) -5.7%
支柱一致性 ×1.23
不计入评分
价格波动 参考 1.5
最终评分 -1.99

市场趋势

短期 中期
行业 Medical Devices (US) 混合的 混合的
Medical Devices (全球的) 混合的 混合的
股票 Accuray Incorporated 混合的 看跌

相关股票

股票 市值 DY P/E(TTM) P/B
ARAY - - - 0.170
ZIMV 535 M - - 1.29
KIDS - - - 2.61
NPCE - - - 38.49
BRKR - 0.32% - 4.10
CLPT - - - 10.76

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

部门 Healthcare
行业 Medical Devices
投资方式 Small Core
内部持股比例 2.27%
机构持股比例 62.55%

所有权

姓名 日期 持有股份
Tcw Group Inc 30 Sep 2026 688,198
Armistice Capital, Llc 30 Jun 2026 143,400
Neuberger Berman Group Llc 30 Sep 2026 134,620
Weber Capital Management Llc /Adv 30 Sep 2026 120,815
Aqr Capital Management Llc 30 Jun 2026 67,976
Renaissance Technologies Llc 30 Sep 2026 49,757
Dafna Capital Management Llc 30 Jun 2026 42,013
Fmr Llc 30 Sep 2026 39,881
Millennium Management Llc 30 Jun 2026 39,729
Silverback Asset Management Llc 30 Jun 2026 36,250
Geode Capital Management, Llc 30 Sep 2026 31,831
Kovack Advisors, Inc. 30 Sep 2026 28,149

该时间范围内无数据。

日期 类型 细节
13 Nov 2026 Yahoo Finance Accuray Closes TCW Transaction, Strengthening Balance Sheet to Support Long-Term Value Growth
Accuray Incorporated (NASDAQ: ARAY) today announced that it has completed its financing transaction with TCW Asset Management Company LLC ("TCW"), the company's primary lender and largest shareholder. The transaction significantly reduces Accuray's debt, adds new capital and waives certain…
05 Nov 2026 Yahoo Finance Accuray (ARAY) Q1 2027 Earnings Call Transcript
Service margins and cost cuts offset a product revenue slide.
05 Nov 2026 Yahoo Finance Accuray Incorporated Q1 2027 Earnings Call Summary
Moby summary of Accuray Incorporated's Q1 2027 earnings call…
05 Nov 2026 Yahoo Finance Accuray Inc (ARAY) (Q1 2027) Earnings Call Highlights: Service Strength and Cost Cuts Offset by ...
Accuray Inc (ARAY) posted 4% service revenue growth and a $2.5 million adjusted EBITDA profit, but an 8% total revenue decline and weak product orders weighed on the quarter.
04 Nov 2026 Yahoo Finance RaySearch Laboratories AB (RSLBF) (Q3 2026) Earnings Call Highlights: Record Sales and 18% ...
RaySearch Laboratories AB (RSLBF) posted record Q3 2026 sales of SEK 394 million with license orders up 65%, though a softer license sales mix and negative free cash flow tempered the quarter.
04 Nov 2026 Yahoo Finance Accuray: Fiscal Q1 Earnings Snapshot
(ARAY) on Wednesday reported fiscal first-quarter net income of $10.1 million, after reporting a loss in the same period a year earlier.
04 Nov 2026 Yahoo Finance Accuray Announces 1-for-40 Reverse Stock Split
Accuray Incorporated (NASDAQ: ARAY) announced today that its Board of Directors has approved a 1-for-40 reverse stock split of the Company's common stock and a corresponding decrease to the authorized number of shares of common stock. The reverse stock split is intended to increase the per-share…
04 Nov 2026 Yahoo Finance Accuray Reports Fiscal 2027 First Quarter Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2026…
30 Oct 2026 Yahoo Finance Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Sofiane Laoussadi, the company's new Senior Vice President, Global Services & Solutions.
21 Oct 2026 Yahoo Finance Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2027, ended September 30, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on November 4, 2026…
06 Oct 2026 Yahoo Finance Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
Accuray Incorporated (Nasdaq: ARAY) today announced that stockholders approved all proposals presented at the company's Special Meeting of Stockholders held on October 6, 2026, enabling Accuray to complete its previously announced transactions with TCW Asset Management Company LLC, the company's…
28 Sep 2026 Yahoo Finance Accuray partners with Samsung NeuroLogica on CyberKnife imaging
The agreements bring together mobile CT capabilities and precision treatment delivery expertise to improve anatomical visualisation during radiotherapy.
27 Sep 2026 Yahoo Finance Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
Accuray Incorporated (NASDAQ: ARAY) today announced that it had entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp. ("Samsung NeuroLogica") to pursue advanced volumetric imaging capabilities for the CyberKnife® System. The announcement coincides with the American Society…
14 Sep 2026 Yahoo Finance What Accuray’s (ARAY) $8 Million RaySearch Deal Means for Its Adaptive Therapy Push
Accuray Inc.’s (NASDAQ:ARAY) recent agreement with RaySearch Laboratories around an extended alliance, is a major step toward online adaptive radiation therapy. The integration of Accuray’s imaging technology and photon-based radiation therapy platforms with RaySearch’s proprietary planning and…
11 Sep 2026 Yahoo Finance Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, and RaySearch Laboratories AB (publ) today announced that they had entered into a definitive agreement providing for an expanded collaboration aimed at accelerating Accuray's adoption of…
28 Aug 2026 Yahoo Finance Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter
On August 19, Accuray Incorporated (NASDAQ:ARAY) held its fiscal fourth-quarter and full-year 2026 earnings call, laying out a business caught between a genuine financial rescue and a China market that is still bleeding revenue. Total net revenue fell 21% in the quarter to $100.9 million, and the…
26 Aug 2026 Yahoo Finance Accuray (ARAY) Q4 2026 Earnings Call Transcript
Transformation plan delivered $20M in cost savings as China headwinds pressured product revenue 42%.
20 Aug 2026 Yahoo Finance Accuray Inc (ARAY) (Q4 2026) Earnings Call Highlights: Strategic Transformation and Financial ...
Accuray exceeds cost-saving targets and strengthens balance sheet through TCW deal, despite revenue headwinds from China and tariff pressures.
19 Aug 2026 Yahoo Finance Accuray Incorporated Q4 2026 Earnings Call Summary
Moby summary of Accuray Incorporated's Q4 2026 earnings call…
19 Aug 2026 Yahoo Finance Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2026, ended June 30, 2026…
显示更多

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2026 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票